Novo Nordisk sees increased profits despite pandemic

Novo Nordisk sees increased profits despite pandemic

Denmark's Novo Nordisk, the world's number one producer of insulin, on Wednesday reported an eight percent bump to net profits in 2020 despite the pandemic leading to a drop in new patients.

Danish company cuts donations to US politicians

Danish company cuts donations to US politicians

Novo Nordisk pledges insulin supply for Britain

Novo Nordisk pledges insulin supply for Britain

Novo Nordisk cuts jobs as profits slip

Novo Nordisk cuts jobs as profits slip

Denmark’s Novo Nordisk buys UK insulin technology pioneer

Denmark’s Novo Nordisk buys UK insulin technology pioneer

Falling US prices pull down Danish Novo Nordisk shares

Falling US prices pull down Danish Novo Nordisk shares

Danish drugmaker Novo Nordisk profits jump in diabetes scourge

Danish drugmaker Novo Nordisk profits jump in diabetes scourge

Denmark’s Novo Nordisk woos Belgian nano-drug maker

Denmark’s Novo Nordisk woos Belgian nano-drug maker

Denmark’s Novo Nordisk faces diminished profits and price-fixing lawsuit in US

Denmark’s Novo Nordisk faces diminished profits and price-fixing lawsuit in US

Trump pledge sends Danish pharma firms’ stocks down

Trump pledge sends Danish pharma firms’ stocks down

Novo Nordisk to cut 500 jobs in Denmark, 1,000 overall

Novo Nordisk to cut 500 jobs in Denmark, 1,000 overall

‘World’s best CEO’ to retire from Novo Nordisk

‘World’s best CEO’ to retire from Novo Nordisk

Insulin leader Novo Nordisk profits up, but outlook down

Insulin leader Novo Nordisk profits up, but outlook down

Novo ups profit forecast as earnings jump

Novo ups profit forecast as earnings jump

Novo Nordisk CEO named world’s best

Novo Nordisk CEO named world’s best

Novo Nordisk profits rise from insulin sales

Novo Nordisk profits rise from insulin sales

US authorities subpoena Novo Nordisk

US authorities subpoena Novo Nordisk

Novo has best-perfoming CEO outside of US

Novo has best-perfoming CEO outside of US

Novo shares rise as US panel backs obesity drug

Novo shares rise as US panel backs obesity drug

Novo Nordisk reports progress on US permit

Novo Nordisk reports progress on US permit

Denmark’s Novo Nordisk sets up insulin production line in Iran

Denmark’s Novo Nordisk sets up insulin production line in Iran

New Danish agency will test up to 20,000 people a day for coronavirus

New Danish agency will test up to 20,000 people a day for coronavirus